Abolishing HIV-1 infectivity using a polypurine tract-specific G-quadruplex forming oligonucleotide
July 2016
Click for full info +Abolishing HIV-1 infectivity using a polypurine tract-specific G-quadruplex forming oligonucleotide
22 July 2016 |
In this Journal Article:
Health Risk(s):HIV
Product Type(s):Other or N/A
Full Info:
Resource Type:
Citation:
Voges, M., Schneider, C., Sinn, M., Hartig, J.S., Reimer, R., Hauber, J., & Moelling, K. (2016, July 22). BMC Infectious Diseases.
Authors:
Voges, M., Schneider, C., Sinn, M., Hartig, J.S., Reimer, R., Hauber, J., & Moelling, K.
Health Risks(s):
- HIV
Product type(s):
- Other
Topic(s):
URL of resource:
https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-016-1713-x